Log in to save to my catalogue

Mechanism of EBV inducing anti-tumour immunity and its therapeutic use

Mechanism of EBV inducing anti-tumour immunity and its therapeutic use

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7864874

Mechanism of EBV inducing anti-tumour immunity and its therapeutic use

About this item

Full title

Mechanism of EBV inducing anti-tumour immunity and its therapeutic use

Publisher

London: Nature Publishing Group UK

Journal title

Nature (London), 2021-02, Vol.590 (7844), p.157-162

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Tumour-associated antigens (TAAs) comprise a large set of non-mutated cellular antigens recognized by T cells in human and murine cancers. Their potential as targets for immunotherapy has been explored for more than two decades
1
, yet the origins of TAA-specific T cells remain unclear. While tumour cells may be an important source of TAAs fo...

Alternative Titles

Full title

Mechanism of EBV inducing anti-tumour immunity and its therapeutic use

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7864874

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7864874

Other Identifiers

ISSN

0028-0836

E-ISSN

1476-4687

DOI

10.1038/s41586-020-03075-w

How to access this item